HUP0201376A2
(en )
2002-08-28
Thiazoloderivatives and pharmaceutical compositions containing them and process for preparation the compounds
HK1025904A1
(en )
2000-12-01
Pharmaceutical composition for combination of piperidinoalkanol-decongestant
HUP0103256A3
(en )
2002-05-28
Thiobenzimidazole derivatives and pharmaceutical compositions containing the compounds
HUP0203378A3
(en )
2004-07-28
Pharmaceutical compounds and pharmaceutical compositions containing them
HUP0104734A3
(en )
2003-05-28
Pharmaceutical formulations for aerosols with two or more active substances
ZA9811799B
(en )
1999-06-22
Solid galenic form of the controlled release tablet type for the instant and then prolonged release of one or more active substances
HUP0103511A3
(en )
2002-07-29
Oxazole compounds and pharmaceutical compositions containing them and process for preparation the compounds
ZA986889B
(en )
1999-12-28
Controlled release pharmaceutical compositions containing tiagabine
AU5609998A
(en )
1998-08-03
Tablet for the controlled release of active agents
EP1189597A4
(en )
2008-06-18
Oil-core compositions for the sustained release of hydrophobic drugs
HUP0000137A3
(en )
2001-03-28
Controller-release pharmaceutical composition containing anangetics
HUP0200747A2
(en )
2002-06-29
Pharmaceutical compounds and pharmaceutical compositions containing them
EG24463A
(en )
2009-07-16
Modified release pharmaceutical composition
IL126892A0
(en )
1999-09-22
Pharmaceutical compositions for the sustained release of insoluble active principles
AU5820900A
(en )
2001-01-30
Capsule for the controlled release of active substances
AU2001221695A1
(en )
2001-07-24
Solid pharmaceutical compositions for controlled release of active substances
IL121096A0
(en )
1997-11-20
Pharmaceutical compositions for the treatment of liver disease
AU1786799A
(en )
1999-07-05
Composition for the controlled release of active compounds
AU8532798A
(en )
1998-12-30
Compounds which delay the release of active substances
GB9818927D0
(en )
1998-10-21
Pharmaceutical formulation
HUP0003159A3
(en )
2001-07-30
The use of n-monosubstituted-3-oxo-4-aza-5alpha-androst-1-en-17betha-carboxamides for the preparation of pharmaceutical compositions
IL120005A
(en )
2000-08-31
Pharmaceutical compositions for the treatment of the eye
AU2882699A
(en )
1999-09-15
Stabilizing composition for pharmaceutical dosage forms
ZA987799B
(en )
1999-05-26
Pharmaceutical compositions for the controlled release of active substances
GB9817470D0
(en )
1998-10-07
Pharmaceutical formulation